Cemtrex (OTC:CETXP) Stock, Quote.Headers.trade-ideas

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes the Security segment, Industrial Services segment and the Corporate segment. It generates maximum revenue from the Security segment. It geographically operates in USA, UK and India wherein maximum revenue is generated in USA.

News

Penny Stocks

Intraday Update

Markets

Movers

Trading Ideas

AOSL

Adtalem Global Education Inc. Common Stock

ATGE

AVDX

BBIG

BLUE

BLZE

BOOM

BRBR

BTTX

CCXI

CDNA

CETXP

CLNE

DBGI

ENDP

FARM

FNKO

FUBO

GANX

GPRO

HEAR

ILMN

IRTC

JNCE

JYNT

LUNG

Meten EdtechX Education Group Ltd Ordinary Shares

METX

PACK

PEPG

QRTEA

RELY

RXST

STEM

STGW

SWVL

VAPO

VAXX

VRPX

Gainers


	Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.


55 Stocks Moving In Friday&#39;s Mid-Day Session

Small Cap

Pre-Market Outlook

AEZS

ENSV

OPEN

SIOX

SMFL

SONM

TPIC

ZKIN

Gainers


	Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 35% to $3.47 in pre-market trading. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend is expected to be distributed on May 27, 2022.


24 Stocks Moving in Friday&#39;s Pre-Market Session

Asset Sales

Tech

Media

Here&#39;s Why Cemtrex Shares Are Up Today

Cemtrex Inc

Overall the updated analysis reveals a 56% objective response rate (ORR) in patients treated with LODER, with the ORR increasing to 67% in patients whose previously non-resectable tumors became resectable. This marks a significant step forward in potentially improving surgical outcomes for LAPC patients.

Biotech

Health Care

General

SLXN

Silexion Therapeutics Announced New Findings From Its Phase 2 Trial Of LODER In Patients With Non-resectable Locally Advanced Pancreatic Cancer (LAPC) Which Bear KRAS G12D Or G12V Mutation-Filing

GOEV

Canoo Says It Launched Commercial Operations And Activation Center In The United Kingdom;  Expansion Poised To Capitalize On The Strong Demand In The Light Commercial Vehicle Market

Macro Economic Events

Economics

iShares MSCI Israel Capped Investable Market Index Fund

White House's Kirby Said Americans Should Leave While Commercial Travel Is Still Available Amid Israel-Lebanon Conflict

CEVA

CEVA Says It Inked Pact With Edge Impulse To Enable Faster, Easier Development Of Edge AI Applications

Italian automaker Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) is reportedly looking for a new CEO to replace Carlos Tavares.
What Happened: Tavares took the helm of the company in 2021. The company <a href="https://apnews.com/article/stellantis-jeep-ram-ceo-carlos-tavares-6a882961eb47c581e6105d2bc473f57c">told</a> Associated Press on Monday that the look out for a new CEO is part of the normal process of determining leadership succession.
Tavares&#8217; contract is set to expire in 2026, AP reported. There is also a possibility that Tavares will stay in the role for longer, it added.
Earlier this month, President of U.S. Stellantis National Dealer Council (NDC) Kevin Farrish <a href="https://www.benzinga.com/news/24/09/40827607/stellantis-fires-back-at-us-dealer-councils-allegation-of-short-term-decision-making-carmaker-says-p" target="_blank" rel="noreferrer noopener">wrote to company CEO</a> Tavares, accusing him of &#8220;short-term decision-making&#8221; and urged that the CEO spend more to clear older inventory.
Tavares&#8217; decisions, the NDC President said, ended up shrinking the company&#8217;s market share and hurting its many brands. Stellantis, however, said that it takes &#8220;absolute exception&#8221; to the letter, and termed it a &#8220;public personal attack.&#8221;
The company has also faced flack from the United Auto Workers (UAW) union. Last week, <a href="https://www.benzinga.com/news/24/09/40996835/xpeng-touches-production-milestone-of-500k-evs-heres-how-many-electric-cars-the-chinese-company-has">UAW</a> said that it <a href="https://www.benzinga.com/news/24/09/40894503/uaw-files-nlrb-complaint-against-stellantis-over-alleged-contract-violations-says-it-intends-to-make" target="_blank" rel="noreferrer noopener">filed federal unfair labor practice charges</a> at the National Labor Relations Board (NLRB) against Stellantis for alleged violation of the <a href="https://www.benzinga.com/news/23/11/35530931/stellantis-weathered-uaw-strikes-better-than-gm-and-ford-with-less-financial-toll-cfo" target="_blank" rel="noreferrer noopener">labor contract entered into last year</a>.
The union alleges that Stellantis is attempting to move the production of the Dodge Durano SUV out of the U.S. and is also looking to not reopen the idled Belvidere assembly plant in Illinois despite it being promised.
The company, however, said that it has abided with the agreement it entered into last year with the union and will continue to.
Why It Matters: For the first half of 2024, Stellantis reported a 48% fall in net profit to €5.6 billion ($6.22 billion) and a 14% fall in net revenue to €85 billion, owing to a&nbsp;<a href="https://www.benzinga.com/markets/24/06/39477084/stellantis-threatens-to-exit-uk-over-unsustainable-ev-sales-targets-if-this-market-becomes-hostile-f" target="_blank" rel="noreferrer noopener">dip in market share</a>&nbsp;in North America.
"It is an understatement to say that H1 2024 results were disappointing and humbling,"&nbsp;<a href="https://www.benzinga.com/news/earnings/24/07/39959183/stellantis-ceo-earnings-fell-short-of-expectations-expect-20-new-vehicles-this-year" target="_blank" rel="noreferrer noopener">Tavares said</a>&nbsp;at the company's earnings call in July.
&#8220;The Company&#8217;s performance in the first half of 2024 fell short of our expectations, reflecting both a challenging industry context as well as our own operational issues… We have significant work to do, especially in North America, to maximize our long-term potential," he said while also reiterating his personal involvement with the teams in North America to fix the issue.
In the second quarter alone, Stellantis saw its sales in the U.S. fall 21% to 344,993 vehicles.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40996835/xpeng-touches-production-milestone-of-500k-evs-heres-how-many-electric-cars-the-chinese-company-has">XPeng Touches Production Milestone Of 500K EVs: Here&#8217;s How Many Electric Cars The Chinese Company Has Delivered</a></li>
</ul>
Photo courtesy: Shutterstock

STLA

Stellantis Begins Search For New CEO To Succeed Carlos Tavares: Report

FANG

KNTK

Diamondback Energy, Kinetik And EPIC Midstream Announced A Series Of Transactions To Support The Continued Growth And Strengthened Financial Profile Of EPIC Crude Holdings, LP

Contracts

Teledyne FLIR Defense Receives Two Five-Year Requirements Contracts Worth Up To $47M In Total To Provide And Support Nearly Its Entire Range Of Ground Robots To US Government

Raymond James analyst Josh Beck initiates coverage on Maplebear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) with a Market Perform rating.

Initiation

Analyst Ratings

CART

Raymond James Initiates Coverage On Maplebear with Market Perform Rating

SVCO

Silvaco Says It Expanded Its Victory TCAD And Digital Twin Modeling Platform To Planar CMOS, FinFET And Advanced CMOS Technologies

Featured presentations include data from the SYMPHONY Phase 3 trial of AXS-12 in narcolepsy, findings from the CRESCENDO patient survey underscoring the unmet needs of patients with type 1 narcolepsy, and previously reported data on solriamfetol demonstrating improvement in cognitive function in patients with excessive daytime sleepiness (EDS) associated with OSA and narcolepsy.

AXSM

Axsome Therapeutics Announced Seven Presentations On AXS-12 And Solriamfetol At Sleep Europe 2024

Wedbush analyst David Chiaverini upgrades Banc of California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>) from Neutral to Outperform and raises the price target from $14 to $18.

Upgrades

Price Target

BANC

Wedbush Upgrades Banc of California to Outperform, Raises Price Target to $18

Ginkgo Bioworks Announced Its New Partnership With NOVUS International To Develop Advanced Feed Additives Designed To Meet The Evolving Needs Of The Animal Agriculture Industry

As part of the partnership, ScottsMiracle-Gro introduced an AI agent built on&nbsp;Google Cloud Vertex AI that functions as the first-of-its-kind&nbsp;&quot;gardening sommelier&quot; and provides highly tailored gardening advice and product recommendations.

GOOG

ScottsMiracle-Gro, Google Cloud Reveal New Collaboration To Help Transform Company's Customer Experience Using Generative AI

EQT And Sixth Street Announced That The EQTInfrastructure IV And EQT Infrastructure V Funds Have Signed An Agreement To Sell A Minority Stake In EdgeConneX To Funds Managed By Sixth Street

Currently available at Dana facilities across Europe, the Dana Certified Reman&trade;&nbsp;program will extend to an additional 50 locations in&nbsp;North America, Europe, the&nbsp;Middle East,&nbsp;Africa, and&nbsp;China&nbsp;by the end of 2025.

Dana Says It Launched Dana Certified Reman Program Boosting Sustainability And Extending Life Cycles Of Drive Technologies For Off-highway

Ahead of the 2024 U.S. presidential election, Donald Trump has made a bold assertion regarding Ukrainian President Volodymyr Zelenskyy and his political preferences.
What Happened: Trump asserted on Tuesday that Zelenskyy prefers the Democrats to win the upcoming 2024 U.S. election, Reuters reported. Trump made this statement during a rally in western Pennsylvania.
Trump&#8217;s remarks contrast with some of his allies who believe Ukraine would welcome his return, claiming he has the skills to negotiate peace with Russian President Vladimir Putin. 
&#8220;I think Zelenskyy is the greatest salesman in history. Every time he comes into the country, he walks away with 60 billion dollars,&#8221; Trump said.
In response, Vice President Kamala Harris&#8217; campaign criticized Trump for not expressing support for Ukraine&#8217;s victory in the war. 
&#8220;Vice President Harris understands that if America walks away from Ukraine, Putin would be sitting in Kyiv with his eyes on the rest of Europe and our NATO allies,&#8221; stated Morgan Finkelstein, Harris&#8217; national security spokesperson.
Zelenskyy&#8217;s office in Kyiv did not immediately comment. Trump provided no specifics on his peace plan, only mentioning he would call Putin and Zelenskyy to negotiate an accord if he wins the election on November 5. Zelenskyy attending the U.N. General Assembly, emphasized that decisive U.S. action could hasten the end of the war.
See Also: <a href="https://www.benzinga.com/news/24/09/40968413/elon-musk-reacts-after-cathie-wood-labels-gavin-newsoms-threat-to-sue-tesla-ceo-over-memes-unconstit?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Reacts After Cathie Wood Labels Gavin Newsom&#8217;s Threat To Sue Tesla CEO Over Memes &#8216;Unconstitutional&#8217;: &#8216;…But That Didn&#8217;t Stop Them&#8217;</a>
Although Trump mentioned a potential meeting with Zelenskyy no meeting has been scheduled. Over the weekend, Zelenskyy visited a weapons factory in Pennsylvania with Democratic Governor Josh Shapiro, which upset some Trump associates. The visit occurred in a key electoral battleground.
Eastern European Americans, including Ukrainian-Americans and Polish-Americans, have become a crucial voting bloc for both campaigns, especially in Pennsylvania. The U.S. and its allies have provided substantial aid to Ukraine since the Russian invasion began in February 2022.
Why It Matters: The backdrop to Trump&#8217;s claims includes <a href="https://www.benzinga.com/news/24/09/40975071/ukraines-zelenskyy-heads-to-us-to-present-victory-plan-against-russia-to-biden-as-war-drags-for-over">Zelenskyy&#8217;s recent visit </a>to the U.S. to present a &#8220;victory plan&#8221; against Russia to President Joe Biden and other key American leaders.
Additionally, Vice President Kamala Harris has been <a href="https://www.benzinga.com/news/24/09/40811624/kamala-harris-slams-donald-trump-over-friendship-with-russian-president-a-dictator-who-would-eat-you">vocal about her stance</a> on Ukraine, criticizing Trump&#8217;s approach and his &#8220;friendship&#8221; with Putin. Harris emphasized the importance of U.S. support for Ukraine, highlighting the broader implications of the conflict.
Furthermore, Trump has previously claimed to have engaged in <a href="https://www.benzinga.com/news/24/07/39870085/trump-boasts-very-good-phone-call-with-zelenskyy-says-russia-ukraine-will-come-together-and-negotiat">discussions with Zelenskyy</a> about potential peace plans, boasting about a &#8220;very good&#8221; phone call with the Ukrainian leader.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments.&nbsp;<a href="https://www.benzinga.com/gov-trades" target="_blank" rel="noreferrer noopener">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Photos courtesy: Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

Global

Trump Says Ukrainian President Backs Kamala Harris For White House: 'Zelenskyy Is The Greatest Salesman In History'

Interactive Strength Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trnr#NASDAQ">TRNR</a>) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that CLMBR has passed EU-wide compliance requirements, has secured the mandatory CE marking and will begin fulfilling orders immediately from exclusive distributors in Germany, Switzerland and Austria.

TRNR

Interactive Strength Successfully Passes EU Compliance for CLMBR and will Start Fulfilling European and UK Orders Immediately

Cyngn Announced The First Build Of The Next-generation 12,000 Lb Drivemod Tugger Has Been Successfully Completed At The Facility Of Its Oem Partner, Motrec International Inc

PayMate India ("PayMate"), a leading provider of B2B payments and services with reputable investors such as Visa &amp; Lightbox, today announced that it has entered into a binding term sheet (the "Proposed Transaction") for the potential acquisition of DigiAsia Bios Pte Ltd., Singapore, a leading Fintech-as-a-Service (FaaS) company in Indonesia and a fully owned subsidiary of DigiAsia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) ("DigiAsia").
Under the terms of the Proposed Transaction, an enterprise valuation of US $400 Million for DigiAsia's business has been determined. Additionally, post the Proposed Transaction, PayMate intends to invest up to US $25 Million in cash, the aggregate financing structure and terms will be finalized in mutual agreement. PayMate and DigiAsia will continue joint due diligence on both entities, identification of the right transaction structure, entering into definitive agreements and the necessary corporate and regulatory approvals of PayMate and DigiAsia which is expected to take up to 60 days. Subsequent to the closing of the Proposed Transaction, PayMate intends to initiate proceedings to list the combined entity in India.

IPOs

FAAS

PayMate to Acquire Fintech-as-a-Service (FaaS) Company DigiAsia Bios for $400M, Plans Indian Market Listing

<div>Mechanistic findings explain ibezapolstat&#39;s properties of lacking cross resistance with other antibiotics and not fostering the emergence of Enterococcus, including vancomycin-resistant strains, a unique differentiation among anti-CDI antibiotics.&nbsp;Planning continues to prepare to advance ibezapolstat into international Phase 3 clinical trials for treatment of C. difficile Infection (CDI)</div>

ACXP

Acurx Reports Results From Its Research With Ibezapolstat In Collaboration With Leiden University Medical Center

Cemtrex GAAP EPS of -$7.33, revenue of $59.71M

Cemtrex, Inc. (CETX) Q4 2023 Earnings Call Transcript

Cemtrex, Inc. (CETX) Q1 2024 Earnings Call Transcript

Cemtrex, Inc. (CETX) Q2 2024 Earnings Call Transcript

Cemtrex, Inc. (CETX) Q3 2024 Earnings Call Transcript

CETX

Press Releases

Cemtrex Issues Shareholder Letter and Provides Corporate Update

Cemtrex Announces Beta Release of Pioneering AI Gun Detection Feature

Cemtrex's Advanced Industrial Services Secures New Orders Totaling $2.1 Million

Cemtrex's Vicon Industries to Attend ISC West 2024

Financing

Cemtrex, Inc. Announces Pricing of $10 Million Upsized Underwritten Public Offering

Cemtrex, Inc. Announces Closing of $10 Million Upsized Underwritten Public Offering

Cemtrex to Host Fiscal Second Quarter 2024 Financial Results Conference Call on Tuesday, May 14, 2024 at 5:00 p.m. Eastern Time

Earnings

Cemtrex Reports Second Quarter 2024 Financial Results

Cemtrex to Host Fiscal Third Quarter 2024 Financial Results Conference Call on Wednesday, August 14, 2024 at  5:00 p.m. Eastern Time

Cemtrex Reports Third Quarter 2024 Financial Results

Cemtrex

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Cemtrex

Cemtrex (CETXP) Forecast

Cemtrex (OTC:CETXP) Stock, Quote.Headers.trade-ideas